![Kristine Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristine Ball
Vorstandsvorsitzender bei
Antiva Biosciences, Inc.
Vermögen: - $ am 31.08.2026
Profil
Kristine McClintock Ball is currently President & Chief Executive Officer at Antiva Biosciences, Inc. since 2023.
Also holds positions as Director at the National Kidney Foundation of Northern California and Independent Director at Oruka Therapeutics, Inc. starting in 2024.
Former roles include Chief Executive Officer & Director at Soteria Biotherapeutics, Inc. from 2020 to 2022; Independent Director at Forty Seven LLC from 2018 to 2020; Independent Director at Atreca, Inc. from 2020 to 2024; Chief Financial Officer & SVP-Corporate Strategy at Menlo Therapeutics, Inc. from 2017 to 2020; Chief Financial Officer & Senior Vice President at Relypsa, Inc. from 2012 to 2016; CFO, Senior VP-Administration & Finance at KAI Pharmaceuticals, Inc. from 2005 to 2012; Vice President-Finance at Exelixis, Inc. from 2000 to 2005; and Senior Manager at Ernst & Young LLP from 1998 to 2000.
Education includes undergraduate studies at Babson College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 02.06.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Kristine Ball
| Unternehmen | Position | Beginn |
|---|---|---|
National Kidney Foundation of Northern California
 National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Vorstandsvorsitzender | 27.04.2023 |
Ehemalige bekannte Positionen von Kristine Ball
| Unternehmen | Position | Ende |
|---|---|---|
| ATRECA, INC. | Direktor/Vorstandsmitglied | 01.01.2024 |
Soteria Biotherapeutics, Inc.
 Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Vorstandsvorsitzender | 01.08.2022 |
| FORTY SEVEN, INC. | Direktor/Vorstandsmitglied | 07.04.2020 |
| YARROW BIOSCIENCE, INC. | Finanzdirektor/CFO | 01.03.2020 |
| RELYPSA INC | Finanzdirektor/CFO | 01.10.2016 |
Ausbildung von Kristine Ball
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
National Kidney Foundation of Northern California
National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | |
Soteria Biotherapeutics, Inc.
Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Health Technology |
